Skip to main content
CCAP
NASDAQ Unknown

Crescent BDC Posts $0.37 NII, NAV Slips to $17.72; Authorizes $50M Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Asset Management Stocks · Financial
Sentiment info
Neutral
Importance info
7
Price
$9.24
Mkt Cap
$340.457M
52W Low
$8.395
52W High
$15.175
52W Position info
10% above low
Off High info
39% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

CCAP is trading near its 52-week low of $8.395 (10% above the low).

Summary

Crescent BDC earned $0.37 per share in Q3 2026, covering its $0.34 dividend, while NAV per share declined to $17.72 from $19.10 at year-end. The Board authorized a $50 million buyback and Sun Life plans to buy up to $25 million more in the open market.


Key Events · Earnings and Guidance · CCAP

  • Q3 NII Covers Dividend

    Net investment income was $0.37 per share versus a $0.34 regular quarterly distribution; total investment income rose to $36.9 million from $36.3 million in Q2.

  • NAV Per Share Falls to $17.72

    NAV per share declined to $17.72 at September 30, 2026 from $19.10 at December 31, 2025, and the nine-month net decrease in net assets from operations was $8.6 million versus a $26.0 million increase a year earlier.

  • $50M Buyback Authorized

    On November 5, 2026 the Board authorized repurchases of up to $50 million of common stock through an independent broker under a Rule 10b5-1 plan.

  • Sun Life to Buy Up to $25M

    Sun Life plans to purchase up to an additional $25 million of common stock in the open market through an independent third-party broker under a Rule 10b5-1 plan.


Analysis · CCAP · Unknown

Q3 net investment income of $0.37 per share covers the $0.34 base dividend, but NAV per share fell to $17.72 from $19.10 at year-end 2025 and the nine-month net result swung to a $8.6 million decrease from operations. Against that backdrop the Board authorized a $50 million repurchase program on November 5, 2026 and Sun Life plans to buy up to an additional $25 million in the open market — together roughly $75 million of potential demand for a company with a $340 million market cap, which is meaningful support for a stock trading well below its NAV. The trade-off: buybacks at a discount to NAV are accretive to remaining holders, but they compete for capital with debt reduction at 1.36x net debt-to-equity.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 36.6% of the 2965 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CCAP was trading at $9.24 on NASDAQ in the Unknown sector, with a market capitalization of approximately $340.5M. The 52-week trading range was $8.40 to $15.18. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CCAP - Latest Insights

CCAP
Nov 09, 2026, 4:07 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.24
Real-time Price: $9.24 info
Change: $0 (0%) info
Market Cap: $340.457M info
CCAP
Aug 10, 2026, 4:35 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $9.24 info
Change: -$1.99 (-18%) info
Market Cap: $340.457M info
CCAP
Aug 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $9.24 info
Change: -$1.99 (-18%) info
Market Cap: $340.457M info
CCAP
Aug 10, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $11.23
Real-time Price: $9.24 info
Change: -$1.99 (-18%) info
Market Cap: $340.457M info
CCAP
Jul 01, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $11.10
Real-time Price: $9.24 info
Change: -$1.86 (-17%) info
Market Cap: $340.457M info